Detalhe da pesquisa
1.
Validation of the Artificial Intelligence Prognostic Scoring System for Myelodysplastic Syndromes in chronic myelomonocytic leukaemia: A novel approach for improved risk stratification.
Br J Haematol;
204(4): 1529-1535, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38411250
2.
Response to erythropoietic-stimulating agents in patients with chronic myelomonocytic leukemia.
Eur J Haematol;
97(1): 33-8, 2016 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26341961
3.
Machine Learning Improves Risk Stratification in Myelodysplastic Neoplasms: An Analysis of the Spanish Group of Myelodysplastic Syndromes.
Hemasphere;
7(10): e961, 2023 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37841754
4.
FLAG-IDA regimen (fludarabine, cytarabine, idarubicin and G-CSF) in the treatment of patients with high-risk myeloid malignancies.
Leuk Res;
26(8): 725-30, 2002 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12191567
5.
Results of treatment with azacitidine in patients aged ≥ 75 years included in the Spanish Registry of Myelodysplastic Syndromes.
Leuk Lymphoma;
55(6): 1300-3, 2014 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23952246
6.
Cefepime plus amikacin versus piperacillin-tazobactam plus amikacin for initial antibiotic therapy in haematology patients with febrile neutropenia: results of an open, randomized, multicentre trial.
J Antimicrob Chemother;
50(1): 79-88, 2002 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12096010
7.
Analysis of factors associated with low peripheral blood progenitor cell collection in normal donors.
Transfusion;
42(1): 4-9, 2002 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-11896306
8.
Second mobilization and collection of peripheral blood progenitor cells in healthy donors is associated with lower CD34(+) cell yields.
J Hematother Stem Cell Res;
11(4): 705-9, 2002 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12201959